LEADER 02404nam 22004575 450 001 9910253917103321 005 20200705101153.0 010 $a3-319-50669-2 024 7 $a10.1007/978-3-319-50669-2 035 $a(CKB)3710000001109682 035 $a(DE-He213)978-3-319-50669-2 035 $a(MiAaPQ)EBC4825716 035 $a(PPN)199769702 035 $a(EXLCZ)993710000001109682 100 $a20170317d2017 u| 0 101 0 $aeng 135 $aurnn|008mamaa 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aDictionary of Pharmaceutical Medicine /$fby Gerhard Nahler 205 $a4th ed. 2017. 210 1$aCham :$cSpringer International Publishing :$cImprint: Springer,$d2017. 215 $a1 online resource (X, 396 p.) 311 $a3-319-50668-4 327 $aDictionary of pharmaceutical medicine -- Abbreviations/acronyms -- Selected bibliography -- Useful websites. 330 $aThis dictionary defines various terms typically used in pharmaceutical medicine. A new, 4th edition includes adaptations of the text to the steadily increasing regulatory requirements, particularly in the area of genetics/gene therapy, product quality (e.g., protection against falsified medicines) and of product safety (pharmacovigilance). Further evolving areas that are covered by the 4th edition are typical ?grey zones? (health effects often borderline to medicinal products) such as cosmetics and dietary supplements where misleading information is prohibited on one hand but where any health claims need formal authorisation on the other. These but also other areas are reviewed and presented in an updated and ? if justified ? in an enlarged form. 606 $aPharmaceutical technology 606 $aPharmacy 606 $aPharmaceutical Sciences/Technology$3https://scigraph.springernature.com/ontologies/product-market-codes/B21010 606 $aPharmacy$3https://scigraph.springernature.com/ontologies/product-market-codes/F00008 615 0$aPharmaceutical technology. 615 0$aPharmacy. 615 14$aPharmaceutical Sciences/Technology. 615 24$aPharmacy. 676 $a615.19 700 $aNahler$b Gerhard$4aut$4http://id.loc.gov/vocabulary/relators/aut$0927850 906 $aBOOK 912 $a9910253917103321 996 $aDictionary of Pharmaceutical Medicine$92084571 997 $aUNINA